Home  >  Products  >  GTF2A1 (general transcription factor IIA, 1, 19/37kDa) Blocking Peptide (the C terminal of GTF2A1)(100ug)
GTF2A1 (general transcription factor IIA, 1, 19/37kDa) Blocking Peptide (the C terminal of GTF2A1)(100ug)

GTF2A1 (general transcription factor IIA, 1, 19/37kDa) Blocking Peptide (the C terminal of GTF2A1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-GTF2A1 Antibody (ARP31333_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAPP44093
Size: 100ug
Weight: 37kDa
Gene: 2957
Format: Lyophilized powder
Target: Transcription initiation factor IIA . and . chains (GTF2A1, TFIIA p35 and p19 subunits, TFIIAL) binding ability of TLP is required for characteristic cytoplasmic localization of TLP. TFIIA may regulate the intracellular molecular state and the function of TLP through its property of binding to TLP.
Alternative names: MGC129969; MGC129970; TF2A1; TFIIA
See Full Product Listings >